1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Liu X, Yu Y, Wang M, et al. The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990-2017. Cancer Commun (Lond), 2020, 40(11): 611-619.
|
3. |
Fan Y, Jiang Y, Gong L, et al. Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: Results from the global burden of disease study 2019. Front Public Health, 2023, 11: 1054200.
|
4. |
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet, 2021, 397(10292): 2337-2360.
|
5. |
Zhou RX, Liao HJ, Hu JJ, et al. Global burden of lung cancer attributable to household fine particulate matter pollution in 204 countries and territories, 1990 to 2019. J Thorac Oncol, 2024, 19(6): 883-897.
|
6. |
GBD 2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med, 2021, 9(9): 1030-1049.
|
7. |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1204-1222.
|
8. |
Liang Y, Zhang N, Wang M, et al. Distributions and trends of the global burden of colorectal cancer attributable to dietary risk factors over the past 30 years. Nutrients, 2023, 16(1): 132.
|
9. |
Rehman S, Rehman E, Ikram M, et al. Cardiovascular disease (CVD): Assessment, prediction and policy implications. BMC Public Health, 2021, 21(1): 1299.
|
10. |
Zou J, Sun T, Song X, et al. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: A systematic analysis of GBD 2019 data. Respir Res, 2022, 23(1): 90.
|
11. |
Yang D, Liu Y, Bai C, et al. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett, 2020, 468: 82-87.
|
12. |
Tang S, Meng J, Zhao X, et al. Trends of ischemic heart disease mortality attributable to smoking in the five countries with the highest number of smokers during 1990-2019: An age-period-cohort analysis. Arch Med Sci, 2024, 20(1): 43-53.
|
13. |
Yin P, Brauer M, Cohen AJ, et al. The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: An analysis for the Global Burden of Disease Study 2017. Lancet Planet Health, 2020, 4(9): e386-e398.
|
14. |
Song C, Wu L, Xie Y, et al. Air pollution in China: Status and spatiotemporal variations. Environ Pollut, 2017, 227: 334-347.
|
15. |
Zhou D, Yang Y, Zhao Z, et al. Air pollution-related disease and economic burden in China, 1990-2050: A modelling study based on Global burden of disease. Environ Int, 2025, 196: 109300.
|
16. |
Semple S, Apsley A, Azmina Ibrahim T, et al. Fine particulate matter concentrations in smoking households: Just how much secondhand smoke do you breathe in if you live with a smoker who smokes indoors? Tob Control, 2015, 24(e3): e205-e211.
|
17. |
Grahn K, Gustavsson P, Andersson T, et al. Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD): A population-based cohort study in Stockholm, Sweden. Environ Res, 2021, 200: 111739.
|
18. |
Zhang R, He Y, Wei B, et al. Nasopharyngeal carcinoma burden and its attributable risk factors in China: Estimates and forecasts from 1990 to 2050. Int J Environ Res Public Health, 2023, 20(4): 2926.
|
19. |
Ma J, Jemal A, Fedewa SA, et al. The American Cancer Society 2035 challenge goal on cancer mortality reduction. CA Cancer J Clin, 2019, 69(5): 351-362.
|
20. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
21. |
Frick C, Rumgay H, Vignat J, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: A population-based study. Lancet Glob Health, 2023, 11(11): e1700-e1712.
|
22. |
Catelan D, Biggeri A, Bucchi L, et al. Epidemiologic transition of lung cancer mortality in Italy by sex, province of residence and birth cohort (1920-1929 to 1960-1969). Int J Cancer, 2023, 153(10): 1746-1757.
|
23. |
Hansen MS, Licaj I, Braaten T, et al. Smoking related lung cancer mortality by education and sex in Norway. BMC Cancer, 2019, 19(1): 1132.
|
24. |
Guo L, Zhu C, Cai L, et al. Global burden of lung cancer in 2022 and projected burden in 2050. Chin Med J (Engl), 2024, 137(21): 2577-2582.
|
25. |
Desjardin JT, Chikwe J, Hahn RT, et al. Sex differences and similarities in valvular heart disease. Circ Res, 2022, 130(4): 455-473.
|
26. |
Jin EH, Han K, Shin CM, et al. Sex and tumor-site differences in the association of alcohol intake with the risk of early-onset colorectal cancer. J Clin Oncol, 2023, 41(22): 3816-3825.
|
27. |
Alberg AJ, Wallace K, Silvestri GA, et al. Invited commentary: The etiology of lung cancer in men compared with women. Am J Epidemiol, 2013, 177(7): 613-616.
|
28. |
Honda A, Inoue KI, Higashihara M, et al. Differential pattern of cell death and ROS production in human airway epithelial cells exposed to quinones combined with heated-PM2. 5 and/or Asian sand dust. Int J Mol Sci, 2023, 24(13): 10544.
|
29. |
Wang Y, Zhong Y, Liao J, et al. PM2. 5-related cell death patterns. Int J Med Sci, 2021, 18(4): 1024-1029.
|
30. |
Wang H, Fan Q, Liang Q, et al. Human CYP1A1-activated aneugenicity of aflatoxin B1 in mammalian cells and its combined effect with benzo(a)pyrene. Chem Biol Interact, 2024, 392: 110923.
|
31. |
Li S, Chen H, Man J, et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med, 2021, 10(5): 1889-1899.
|
32. |
胡守财, 杨成龙, 马浩天, 等. 1990-2019年中国饮酒所致的食管癌疾病负担趋势及男女对比分析. 中国胸心血管外科临床杂志, 2025, 32(4): 500-507.Hu SC, Yang CL, Ma HT, et al. Trends in Chinese esophageal cancer burden of disease due to high alcohol use and comparative analysis of males and females from 1990 to 2019. Chin J Clin Thorac Cardiovasc Surg, 2025, 32(4): 500-507.
|
33. |
胡守财, 陶堰成, 马浩天, 等. 1990-2019年中国非风湿性瓣膜性心脏病疾病负担及变化趋势分析. 中国循环杂志, 2024, 39(8): 806-812.Hu SC, Tao YC, Ma HT, et al. Disease burden and changing trend of non-rheumatic valvular heart disease from 1990 to 2019 in China. Chin Circ J, 2024, 39(8): 806-812.
|
34. |
Yu G, Gong X, Xu Y, et al. The global burden and trends of four major types of heart disease, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Public Health, 2023, 220: 1-9.
|
35. |
Ren F, Liu G. Global, regional, and national burden and trends of air pollution-related neoplasms from 1990 to 2019: An observational trend study from the Global Burden of Disease Study 2019. Ecotoxicol Environ Saf, 2024, 285: 117068.
|